ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $256,000 | -2.3% | 9,111 | -9.7% | 0.00% | – |
| Q4 2020 | $262,000 | -73.7% | 10,087 | -68.1% | 0.00% | -100.0% |
| Q1 2020 | $998,000 | -45.5% | 31,655 | +3.1% | 0.00% | -50.0% |
| Q4 2019 | $1,831,000 | -36.6% | 30,712 | -61.0% | 0.00% | -33.3% |
| Q3 2019 | $2,890,000 | +3.1% | 78,845 | +30.9% | 0.00% | 0.0% |
| Q2 2019 | $2,803,000 | +20.2% | 60,249 | +14.7% | 0.00% | +50.0% |
| Q3 2018 | $2,331,000 | +106.6% | 52,544 | +82.6% | 0.00% | +100.0% |
| Q2 2018 | $1,128,000 | -45.9% | 28,775 | -0.1% | 0.00% | -50.0% |
| Q1 2018 | $2,084,000 | +29.9% | 28,812 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $1,604,000 | -18.2% | 24,367 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $1,961,000 | +22.9% | 23,980 | +39.2% | 0.00% | 0.0% |
| Q1 2015 | $1,595,000 | – | 17,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |